MX9602542A - Formulaciones farmaceuticas que comprenden politiourea y metodo para su uso. - Google Patents

Formulaciones farmaceuticas que comprenden politiourea y metodo para su uso.

Info

Publication number
MX9602542A
MX9602542A MX9602542A MX9602542A MX9602542A MX 9602542 A MX9602542 A MX 9602542A MX 9602542 A MX9602542 A MX 9602542A MX 9602542 A MX9602542 A MX 9602542A MX 9602542 A MX9602542 A MX 9602542A
Authority
MX
Mexico
Prior art keywords
oligomers
polytiourea
pharmaceutical formulations
formulations including
polythioureas
Prior art date
Application number
MX9602542A
Other languages
English (en)
Spanish (es)
Inventor
Michael J Mullins
William A Fordyce
William J Kruper
Norton P Peet
Alan D Cardin
Original Assignee
Merrell Pharma Inc
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc, Dow Chemical Co filed Critical Merrell Pharma Inc
Publication of MX9602542A publication Critical patent/MX9602542A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9602542A 1994-01-03 1995-01-03 Formulaciones farmaceuticas que comprenden politiourea y metodo para su uso. MX9602542A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17658694A 1994-01-03 1994-01-03
PCT/US1995/000118 WO1995018791A1 (en) 1994-01-03 1995-01-03 Pharmaceutical formulations comprising polythiourea and method of use thereof

Publications (1)

Publication Number Publication Date
MX9602542A true MX9602542A (es) 1997-05-31

Family

ID=22644965

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9602542A MX9602542A (es) 1994-01-03 1995-01-03 Formulaciones farmaceuticas que comprenden politiourea y metodo para su uso.

Country Status (23)

Country Link
US (1) US6086864A (enExample)
EP (1) EP0738261B1 (enExample)
KR (1) KR100362343B1 (enExample)
CN (1) CN1070180C (enExample)
AP (1) AP638A (enExample)
AT (1) ATE178595T1 (enExample)
AU (1) AU693853B2 (enExample)
CA (1) CA2179988C (enExample)
CZ (1) CZ197996A3 (enExample)
DE (1) DE69508913T2 (enExample)
DK (1) DK0738261T3 (enExample)
ES (1) ES2133734T3 (enExample)
FI (1) FI962725A0 (enExample)
GR (1) GR3030521T3 (enExample)
HU (1) HUT74694A (enExample)
IL (1) IL112174A (enExample)
MX (1) MX9602542A (enExample)
NO (1) NO306613B1 (enExample)
NZ (1) NZ279587A (enExample)
OA (1) OA10367A (enExample)
TW (1) TW303377B (enExample)
WO (1) WO1995018791A1 (enExample)
ZA (1) ZA9410408B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6186659B1 (en) * 1998-08-21 2001-02-13 Agilent Technologies Inc. Apparatus and method for mixing a film of fluid
CN105582020B (zh) * 2014-10-21 2019-04-16 浙江大学 一种线形聚硫脲和超支化聚硫脲在制备抗肿瘤药物及抗病毒或抗菌药物中的应用
CN107236128A (zh) * 2017-06-21 2017-10-10 华南理工大学 一种异腈、硫和胺的多组分聚合制备聚硫脲的方法及该聚硫脲的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE544868A (enExample) *
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
US2868834A (en) * 1955-02-01 1959-01-13 Ciba Pharm Prod Inc Manufacture of new polythioureas
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
ZA9094B (en) * 1989-01-11 1990-10-31 Merrell Dow Pharma Heparin fraction with anti-hiv activity
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5124149A (en) * 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
DK0498095T3 (da) * 1991-02-05 1995-06-19 Merrell Dow Pharma Sulfoniske stilbenderivater til behandling af virussygdomme
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
NZ249032A (en) * 1992-02-20 1996-09-25 Merrell Dow Pharma Stilbene disulphonic acid derivatives substituted in the 4- and 4'-positions by thioureido, thiocarbonate ester, and thiocarbamate and thiocarbamoyloxy (and -omino) and thioamide groups; use in treating viral diseases

Also Published As

Publication number Publication date
KR100362343B1 (ko) 2003-11-28
NO962782L (no) 1996-09-02
CN1070180C (zh) 2001-08-29
AU1675695A (en) 1995-08-01
AP9600842A0 (en) 1996-07-31
ES2133734T3 (es) 1999-09-16
HU9601813D0 (en) 1996-09-30
NO962782D0 (no) 1996-07-02
ZA9410408B (en) 1995-12-11
FI962725A7 (fi) 1996-07-02
AP638A (en) 1998-04-14
IL112174A (en) 1999-05-09
CN1138323A (zh) 1996-12-18
ATE178595T1 (de) 1999-04-15
DK0738261T3 (da) 1999-10-18
NO306613B1 (no) 1999-11-29
CA2179988C (en) 2002-10-29
OA10367A (en) 2001-11-19
DE69508913D1 (de) 1999-05-12
EP0738261A1 (en) 1996-10-23
TW303377B (enExample) 1997-04-21
EP0738261B1 (en) 1999-04-07
NZ279587A (en) 1997-04-24
CA2179988A1 (en) 1995-07-13
US6086864A (en) 2000-07-11
HUT74694A (en) 1997-01-28
FI962725L (fi) 1995-07-02
CZ197996A3 (en) 1996-12-11
DE69508913T2 (de) 1999-12-02
GR3030521T3 (en) 1999-10-29
AU693853B2 (en) 1998-07-09
FI962725A0 (fi) 1996-07-02
WO1995018791A1 (en) 1995-07-13
IL112174A0 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
HUP0003323A2 (hu) Vorikonazolt tartalmazó gyógyászati készítmények
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
AR033548A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
ES2120042T3 (es) Polimero de varilla rigida a base de piridobisimidazol.
IT1282352B1 (it) Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
GT199800046A (es) Compuestos de pirazina.
CY1110988T1 (el) Ταχεως αποσαθρουμενο στερεο παρασκευασμα
UY25544A1 (es) Forma de dosificación de nefazodona
ES2084944T3 (es) Amidas terapeuticas.
PT100812A (pt) Composicoes farmaceuticas para administracao sublingual ou bucal de agentes terapeuticos, nomeadamente polipeptidos
MX9205937A (es) Sistema de penetracion incrementada de la piel para surtido topico mejorado de farmacos
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
ATE378364T1 (de) Polyamhydride mit therapeutisch verwendbaren abbauprodukten
NO20002785L (no) Adamantanderivater
NO20002786L (no) Adamantanderivater
ES2082723B1 (es) Formulacion farmaceutica de fluoxetina en forma dispersable.
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
BR9713147A (pt) Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal.
PT998287E (pt) Utilizacao de levobupivacaina
AR009089A1 (es) Composiciones para el cuidado del color que comprenden un agente fijador de colorante y un polimero y un metodo para proporcionar cuidado de color
ES2171691T3 (es) Derivados de la colchicina, uso de los mismos y formulaciones que los contienen.
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
BR9607967A (pt) Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo